Mannose‐Binding Lectin Polymorphisms in Clinical Tuberculosis

Citations Over TimeTop 10% of 2003 papers

Abstract

Mannose-binding lectin (MBL) mediates protection against infections by using the complement system, but certain microorganisms may increase infectivity by exploiting this host defense system. Thus, it has been speculated whether genetically determined low MBL levels may confer partial protection against certain intracellular microorganisms, such as Mycobacterium tuberculosis. We investigated MBL alleles in 109 culture-positive human immunodeficiency virus-uninfected patients with tuberculosis living in Denmark and 250 white control subjects. Patients and control subjects were divided into 3 different groups defined by undetectable, low, and high serum MBL concentrations, which correlates to deficient, low, and high expressing MBL genotypes. A significantly decreased frequency of patients with the low-expressing MBL genotype was observed in white patients compared to control subjects. The same tendency also was observed in patients of other ethnic origin. It may be hypothesized that heterozygosity for MBL variant alleles, which encodes low serum MBL levels, is associated with protection against clinical tuberculosis.

Related Papers

• → Human IgA Activates the Complement System Via the Mannan-Binding Lectin Pathway(2001)427 cited
• → Enhancement of Complement Activation and Opsonophagocytosis by Complexes of Mannose-Binding Lectin with Mannose-Binding Lectin-Associated Serine Protease After Binding to Staphylococcus aureus(2002)131 cited
• → Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway(2006)123 cited
• → Mannose-binding Lectin (MBL) and Vascular Complications in Diabetes(2005)34 cited
• → Mannose-binding lectin and lectin pathway in subarachnoid hemorrhage patients(2012)